What other cholesterol drugs might I consider (beyond statins)?
If you’re looking beyond a single class (often statins), the main options are other ways to lower LDL (“bad”) cholesterol, lower triglycerides, or both. Common drug categories include:
- Ezetimibe (lowers intestinal cholesterol absorption)
- PCSK9 inhibitors (lower LDL by increasing LDL removal from the blood)
- Bempedoic acid (lowers LDL in people who need additional LDL reduction)
- Bile-acid sequestrants (bind bile acids in the gut to reduce cholesterol reabsorption)
- Fibrates (mainly for high triglycerides)
- Omega-3 prescription products (mainly for high triglycerides, depending on the formulation)
- Niacin (rarely used now for cholesterol lowering due to side-effect tradeoffs)
Whether any of these fit depends on your current LDL/triglyceride levels, cardiovascular history, diabetes, kidney/liver function, other medicines, and side effects you’ve had.
How do these options compare for LDL vs triglycerides?
Many people ask this because different drugs target different parts of the cholesterol problem:
- For lowering LDL cholesterol: ezetimibe, PCSK9 inhibitors, bempedoic acid, and bile-acid sequestrants are the most direct alternatives/add-ons.
- For high triglycerides: fibrates and certain prescription omega-3 products tend to be the most relevant.
- Niacin can lower both cholesterol fractions, but it’s less commonly used in routine practice because of side effects.
If you tell me your most recent LDL and triglyceride numbers (and whether you’re treating heart disease, diabetes, or both), I can help narrow which categories usually make the most sense.
When are add-on drugs used if statins aren’t enough?
Doctors often step up therapy when:
- LDL goals aren’t reached on the maximally tolerated statin dose, or
- you can’t tolerate a statin or get unacceptable side effects.
In practice, add-on patterns commonly include ezetimibe and/or a PCSK9 inhibitor for LDL-focused treatment, and fibrates or prescription omega-3s when triglycerides are the bigger concern.
What side effects or interactions should you ask about?
Patients often want to know what might be different from statins. Key issues to discuss with your clinician include:
- Ezetimibe: usually well tolerated; still worth asking about liver enzyme checks if combined with statins.
- PCSK9 inhibitors (injections): injection-site reactions are common; ask about allergy risk.
- Bempedoic acid: discuss gout or elevated uric acid history and any muscle/joint symptoms history.
- Bile-acid sequestrants: can cause constipation and may interfere with absorption of other medicines; timing matters.
- Fibrates: important to discuss kidney function and risk when combined with certain other lipid drugs.
- Prescription omega-3s: ask which formulation you’d be using and any bleeding risk concerns, especially if you take blood thinners.
- Niacin: side effects can limit use; ask what your clinician thinks about risks versus benefits for your situation.
Can you use these drugs together, and what’s “typical”?
Combination therapy is common when one drug class doesn’t fully meet goals. Combinations depend on what’s being targeted:
- LDL-focused combinations often involve a statin plus an add-on like ezetimibe or a PCSK9 inhibitor, or non-statin pathways if statins aren’t tolerated.
- Triglyceride-focused combinations depend on triglyceride severity and whether you have diabetes or established cardiovascular disease.
A useful question to ask your prescriber is: “Which lipid number are we trying to move (LDL, non-HDL, triglycerides), and what target do you want me to reach?”
What if I’m considering newer/non-statin options for LDL?
For some people—especially those with difficulty tolerating statins or needing large LDL reductions—non-statin options such as PCSK9 inhibitors or bempedoic acid may be considered. If cost or access is part of the decision, it’s also reasonable to ask whether there are alternatives by insurance coverage.
If you want to compare products, pricing, and patent/exclusivity context, DrugPatentWatch.com can be a helpful reference: https://www.drugpatentwatch.com/
Which cholesterol drugs are considered when triglycerides are very high?
When triglycerides are very high, the priority can shift toward lowering them to reduce pancreatitis risk. In that scenario, fibrates or prescription omega-3 products may be emphasized, and clinicians may also review diet, alcohol intake, blood sugar control, and which medications could be raising triglycerides.
Quick questions that determine the best “other drug” for you
To tailor suggestions, it helps to know:
1) Your latest LDL, HDL, triglycerides (with units if you have them)
2) Whether you have known heart disease, stroke, or diabetes
3) Any statin side effects or intolerance you’ve had
4) Kidney or liver issues and whether you take blood thinners
5) Your current lipid-lowering regimen and dose(s)
If you share those details, I’ll narrow the options to the most plausible categories to discuss with your clinician.
Sources